2B5D.1

ICD-11 MMS 2026-01

Malignant mixed epithelial and mesenchymal tumour of corpus uteri

Description

A primary malignant neoplasm of the uterine corpus characterised by the presence of an epithelial and a mesenchymal component. This category includes carcinosarcoma, carcinofibroma, and adenosarcoma.

Coding note from above levels

For use of this category, reference should be made to the mortality coding rules and guidelines in the Reference Guide.

Index terms

  • Malignant mixed epithelial and mesenchymal tumour of corpus uteri
  • Adenosarcoma of corpus uteri
  • Carcinofibroma of corpus uteri
Show allHide
  • Malignant mixed Mullerian tumour of corpus uteri
  • mixed Müllerian tumour of unspecified site
  • Complex mixed and stromal malignant neoplasms of corpus uteri, isthmus uteri
  • Complex mixed and stromal malignant neoplasms of corpus uteri, endometrium
  • Complex mixed and stromal malignant neoplasms of corpus uteri, myometrium
  • Complex mixed and stromal malignant neoplasms of corpus uteri, fundus uteri

Exclusions from above levels

  • 2A01.1 – Mesenchymal tumour of meninges
  • 2A02.1 – Tumours of cranial or paraspinal nerves
  • http://id.who.int/icd/entity/879154182 – Neoplasms of central nervous system or related structures
Show allHide
  • http://id.who.int/icd/entity/944754984 – Neoplasms of haematopoietic or lymphoid tissues

Sibling codes

  • 2B5D.0 – Malignant mixed epithelial mesenchymal tumour of ovary
  • 2B5D.Y – Malignant mixed epithelial mesenchymal tumour, other specified primary site
  • 2B5D.Z – Malignant mixed epithelial mesenchymal tumour, unspecified primary site

Foundation entity

Malignant mixed epithelial and mesenchymal tumour of corpus uteri – http://id.who.int/icd/entity/1532363988

Allowed postcoordination axes

Part of: 2B5D: Malignant mixed epithelial mesenchymal tumour, primary site › 02: Neoplasms